Pages that link to "Q28142569"

The following pages link to Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter (Q28142569):

Displaying 50 items.

• Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression (Q24611123) (← links)
• Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters (Q24673439) (← links)
• Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature (Q26852514) (← links)
• Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily (Q27010565) (← links)
• Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? (Q27690256) (← links)
• Renal drug transporters and their significance in drug-drug interactions (Q28071292) (← links)
• Functional Domains in the Carnitine Transporter OCTN2, Defective in Primary Carnitine Deficiency (Q28204696) (← links)
• Development and characterization of an animal model of carnitine deficiency (Q28204749) (← links)
• Functional variants of OCTN cation transporter genes are associated with Crohn disease (Q28258410) (← links)
• Absorbing competition for carnitine (Q28362815) (← links)
• Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes (Q28362820) (← links)
• Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes (Q28537671) (← links)
• Solute carrier family 22 member 5 (Q28557296) (← links)
• Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier (Q28575291) (← links)
• Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta (Q28577610) (← links)
• Membrane transporters as mediators of Cisplatin effects and side effects (Q30446860) (← links)
• Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data. (Q30648190) (← links)
• Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research (Q30883430) (← links)
• Xenobiotic, bile acid, and cholesterol transporters: function and regulation. (Q33714593) (← links)
• Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity (Q33828918) (← links)
• Molecular enzymology of carnitine transfer and transport (Q33938860) (← links)
• Role of plasma membrane transporters in muscle metabolism. (Q33973728) (← links)
• Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems (Q33985125) (← links)
• Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis (Q34094462) (← links)
• Pharmacogenomics of drug transporters: the next drug delivery challenge (Q34384333) (← links)
• Carnitine biosynthesis in mammals (Q34501779) (← links)
• Glycosylation of the OCTN2 carnitine transporter: Study of natural mutations identified in patients with primary carnitine deficiency (Q34516657) (← links)
• Pharmacokinetics of L-carnitine (Q34536074) (← links)
• The impact of efflux transporters in the brain on the development of drugs for CNS disorders (Q34558556) (← links)
• The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers (Q35042643) (← links)
• Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats (Q35108977) (← links)
• Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers (Q35156413) (← links)
• Carnitine transport: pathophysiology and metabolism of known molecular defects (Q35188329) (← links)
• Drug transfer and metabolism by the human placenta. (Q35788063) (← links)
• Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins (Q35795744) (← links)
• Molecular and cellular physiology of renal organic cation and anion transport (Q35842999) (← links)
• A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis (Q35869583) (← links)
• Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells (Q35928472) (← links)
• Regulation of organic cation transport. (Q36028353) (← links)
• Acetyl-L-carnitine increases mitochondrial protein acetylation in the aged rat heart (Q36461206) (← links)
• Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells (Q36478844) (← links)
• Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting (Q36491674) (← links)
• Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+) (Q36640736) (← links)
• Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications (Q36808739) (← links)
• The epithelial cholinergic system of the airways. (Q37195830) (← links)
• Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects (Q38026944) (← links)
• The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family (Q38962943) (← links)
• Renal Drug Transporters and Drug Interactions (Q39140289) (← links)
• Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier (Q39239140) (← links)
• The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier (Q39391771) (← links)